About Kondesi
As a technology-driven innovation enterprise, the company focuses on the in vitro diagnostics (IVD) field, integrating R&D, manufacturing, sales, and service. It also has the capability to produce medical consumables and is committed to providing global healthcare institutions with precise and efficient diagnostic solutions.
The company’s core business and technological strengths lie in its product portfolio, which covers the entire spectrum of in vitro diagnostic applications, including nine major areas: biochemical analysis, chemiluminescence, immunoassays, point-of-care testing (POCT), coagulation function testing, urine analysis, blood cell counting, molecular diagnostics, and pathological diagnosis. Through independent R&D, the company has established an integrated AI-driven technology platform that combines “reagents + instruments.” It holds 146 CE certifications for its products and more than 50 registration certificates for Class II and Class III medical devices in China. Its technological barriers span across raw material development, optimization of production processes, and the design of intelligent testing systems.
MoreCompany established
Registered capital
Partner
CE certification
Blogs
Learn about company information and stay up-to-date with industry trends—we’ll provide you with accurate and reliable information.